MedPath

Combating Alzheimer's Through Sleep and Exercise

Not Applicable
Recruiting
Conditions
Dementia
Alzheimer Disease
Interventions
Device: DREEM 2 Headband
Other: Exercise Routine
Registration Number
NCT04855630
Lead Sponsor
University of Miami
Brief Summary

The purpose of this research is to see how sleep and exercise affects dementia risk over time.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  1. Able to perform mild exercise
  2. Able to wear DREEM 2 Headband
  3. Able to wear a Fitbit wrist watch
  4. Able to perform the Everlywell biomarker procedure
  5. Able to Understand and Speak English
  6. Able to operate a digital device like mobile phone, iPad, or computer
  7. Self-reported history of problems with cognitive impairment: memory, concentration, and processing information
  8. Only participants cognitively able and willing to provide consent will be included.
Exclusion Criteria
  1. Prohibited from or unable to perform mild exercise
  2. Unable to wear wrist watch or headband devices, or unable to supply pinprick blood sample for any reason
  3. Unable to speak or understand English
  4. Unable to use mobile device/smartphone technology
  5. Unable or unwilling to consent for any reason.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sleep Only GroupDREEM 2 HeadbandParticipants in this group will wear the DREEM 2 headband for 12 weeks.
Exercise Only GroupExercise RoutineParticipants in this group will workout twice a week for 12 weeks.
Exercise and Sleep GroupExercise RoutineParticipants in this group will take part in a guided exercise program in additional to wearing the DREEM 2 headband for 12 weeks.
Exercise and Sleep GroupDREEM 2 HeadbandParticipants in this group will take part in a guided exercise program in additional to wearing the DREEM 2 headband for 12 weeks.
Primary Outcome Measures
NameTimeMethod
Creatinine LevelsUp to Week 12

Measured from Urine Sample

Triglycerides LevelsUp to Week 12

Measured from blood sample

High-Density Lipoprotein (HDL) LevelsUp to Week 12

Measured from blood sample

Blood PressureUp to Week 12

Measured from Fitbit

Cortisone LevelsUp to Week 12

Measured from Urine Sample

HbA1c LevelsUp to Week 12

Measured from blood sample

Heart RateUp to Week 12

Measured from Fitbit

Total Sleep DurationUp to Week 12

Measured from DREEM 2

Slow Wave Sleep DurationUp to Week 12

Measured from DREEM 2

Total Cholesterol LevelsUp to Week 12

Measured from blood sample

Low-Density Lipoprotein (LDL) LevelsUp to Week 12

Measured from blood sample

High-sensitivity C-reactive protein (hs-CRP) LevelsUp to Week 12

Measured from blood sample

Cortisol LevelsUp to Week 12

Measured from Urine Sample

Melatonin LevelsUp to Week 12

Measured from Urine Sample

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Miami Hospitals

🇺🇸

Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath